We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 50,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/7/2018 18:11 | Hugh Wilson = Cyber Bully | eddie_yates | |
24/7/2018 18:11 | This board seems to have degenerated into a slanging match with some investors looking for a scapegoat for their losses. Investing in aim stocks such as N4 Pharma is a calculated gamble and if investors aren't prepared to absorb losses perhaps the stock market is not for them. | billeeedee | |
24/7/2018 17:59 | But hugh you put so much faith in Nigel who has tried similar projects before which have spectacularly failed! Why should it be different this time..... | nobbygnome | |
24/7/2018 14:58 | How coincidental Westie as I’ve just sold my only 50k!! Hopefully amer will come good one of these days but I’m not holding my breath. Good luck to all here with the exception of that wretch of a man Hugh Bloody Wilson and a few other bell ends!!! I managed to make the vastly sum of £120!! | eddie_yates | |
24/7/2018 14:44 | That's my last 50k away. GL to all that stay. | westmoreland lad | |
24/7/2018 14:05 | A total con - people sniping backwards and forwards , supposedly intelligent people. Judging by this , the kindergarten class are Doctarates in finance. All part and parcel of the same con. As i predicted, DOWN. THE CITY doesnt forgive. Im staying away from this one. I dont like the chat. No confidence whatsoever in the posts. | escapetohome | |
24/7/2018 10:48 | Meanwhile the price slips away.... Hugh you need to work harder... | nobbygnome | |
24/7/2018 10:23 | Didn't fancy actually answering the question then Hugh? I don't want a marketing soundbite about 'seeking out the best in science' I want substance. What about the feasibility grant? Doesn't that mean that MedImmune don't have much skin in the game and that they get the best of both worlds - i.e a free option on a potentially great product with not much effort? If Nuvec doesn't work out, who is more damaged by it - N4 or AZN? | dplewis1 | |
24/7/2018 10:22 | And what of Japan. All quiet on that front still isn’t it. | ih_575893 | |
24/7/2018 09:19 | >> hugh Their 2 drugs were a reformulated NSAID and a reformulated statin. Are they on the market? | nobbygnome | |
24/7/2018 09:15 | dplewis1, AZ sought an early collaboration with N4, not the other way round. As per my quote yesterday, Medimmune seek out the very best in science and secure collaborations with those companies. The fact that AZ is on board and working to make Nuvec a winner should be enough to install confidence in anyone as AZ surely seeNuvec as a winner otherwise they wouldn`t be here. Nobby, Oxford didn`t fail, and as I said, N4 is a different situation as described above. | hughwilson | |
24/7/2018 09:04 | Oh good you-know-hugh is back.. still not actually reading what people say (FYI at no stage has nobby told everyone how superior he is). So, rather than another day of your poorly constructed arguments, why don't you put a number on the likelihood of success for Nuvec? I'm genuinely interested to know and it would provide a baseline that maybe people can work from. Your comments "the probability is Nuvec is going to be huge.." and "the odds are that a deal will be done" mean you're pitching somewhere above a 50% chance of success, would you care to put a number on it? | dplewis1 | |
24/7/2018 08:49 | You are a curious character. How is brininging up some facts from the past anything to do with me being superior! I only wish I looked up his past before I bought shares. The point is he failed miserably in very similar circumstances. | nobbygnome | |
24/7/2018 08:30 | Nobby, the only thing that is being repeated here is you telling everyone how superior you are to everyone else and your constant de-ramp of anything N4P. I would suggest on the next collaboration or deal let alone a tie-up with AZ, you may have a hard time plying your negativity and you too will disappear. | hughwilson | |
24/7/2018 08:25 | So the fact that the Oxford Nutrascience/Pharmas | nobbygnome | |
24/7/2018 08:22 | Nobby, in the instance you mention Nigel was just the CEO. With N4, this is his baby. Nigel is quoted as saying that the reason he left Oxford and started N4 is because he felt that he could do so much better with his own company. Well this is his chance. | hughwilson | |
24/7/2018 08:16 | Yes but you put so much store by Nigel's views and actions that it is important to know his past performance in this sector. | nobbygnome | |
24/7/2018 08:15 | Eddie, you will be part of the mist that evaporates on the bounce. Nobby, what has that got to do with N4 pharma? different company. | hughwilson | |
24/7/2018 08:06 | >> hugh You haven't answered my question about Nigel's performance at Oxford Nutrascience/Pharmas | nobbygnome | |
24/7/2018 08:01 | This is the drug that N4 intends to BETTER. | hughwilson | |
24/7/2018 02:26 | Ken is a very depressed guy who finds solace by spreading his sadness on bulletin boards. | volsung | |
24/7/2018 00:17 | Ken Chung would be great fun on a night out. Hey Ken, you know there are other sentences you can type on a keyboard right? | gettingrichslow | |
23/7/2018 20:59 | The Hugh bashing is the main reason I look in these days!! | eddie_yates |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions